Caring for the smoking asthmatic patient - 31/10/12
Doi : 10.1016/j.jaci.2012.04.015
Riccardo Polosa, MD, PhD a, b, ⁎ 
, Pasquale Caponnetto, PhD b, Mark F. Sands, MD c, d
, Pasquale Caponnetto, PhD b, Mark F. Sands, MD c, d a Institute of Internal Medicine and Clinical Immunology, AOU “Policlinico-Vittorio Emanuele,” Università di Catania, Catania, Italy
b Centro per la Prevenzione e Cura del Tabagismo (CPCT), AOU “Policlinico-Vittorio Emanuele,” Università di Catania, Catania, Italy
c School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY
d Veterans Administration Healthcare System of Western New York, Buffalo, NY
Corresponding author: Riccardo Polosa, MD, PhD, Istituto di Medicina Interna e Immunologia Clinica, Policlinico Universitario, University of Catania, 95100, Catania, Italy.Key words : Asthma, smoking, smoking cessation
Abbreviations used : AHR, ICS
Le texte complet de cet article est disponible en PDF.
Plan
| Disclosure of potential conflict of interest: R. Polosa has received lecture fees from Merck Sharp & Dome, GlaxoSmithKline, and Pfizer and has received research support from Pfizer, Boehringer Ingelheim, Sanofi-Aventis, and Arbi Group Srl. M. F. Sands is Secretary ADT, Chair of the ITE Committee, and Chair of the Asthma in the Elderly Committee of the American Academy of Allergy, Asthma & Immunology (AAAAI). P. Caponnetto declares that he has no relevant conflicts of interest. |
© 2012
Publié par Elsevier Masson SAS.
Vol 130 - N° 5
P. 1221-1224 - novembre 2012 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?